News

Filter

Current filters:

Recombivax

1 to 9 of 133 results

Dynavax presents further Ph III Heplisav data

30-04-2009

Dynavax Technologies presented additional Phase III data showing that the Heplisav hepatitis B vaccine…

Engerix-BHepatitis B VaccineHepatitis B Vaccine RecombinantRecombivax

FDA calls for more info on Dynavax' Heplisav

16-02-2009

Dynavax Technologies has received a communication from the US Food and Drug Administration regarding…

Hepatitis B VaccineRecombivax

Dynavax drops 18.8% as Merck & Co ends accord

12-01-2009

Shares in USA-based Dynavax Technologies Corp dropped 18.8% after Merck & Co decided to end a collaboration…

Hepatitis B VaccineMerck KGaARecombivax

ViRexx presents encouraging early data on HBV vacc

01-09-2008

Canadian therapeutics firm ViRexx Medical Corp has reported encouraging results from the laboratory studies…

Hepatitis B VaccineRecombivax

Big immune response with nasal HBV vacc

01-09-2008

A new study has shown that a nasal hepatitis B vaccine elicits a dramatic immune response in animals…

Hepatitis B VaccineRecombivax

Clinical hold on Heplisav by FDA

31-03-2008

USA-based Dynavax Technologies and drug major Merck & Co say that the Food and Drug Administration has…

Hepatitis B VaccineMerck KGaARecombivax

Emergent to proceed with HBV vaccine study

14-01-2008

US biopharmaceutical firm Emergent BioSolutions says it is to move forward with the next stage of enrollment…

Hepatitis B VaccineRecombivax

Merck & Co recalls certain lots of Pedvaxhib and Comvax

17-12-2007

US drug major Merck & Co has initiated a voluntary recall of 11 lots of its Haemophilus influenzae type…

ComvaxHaemophilus b Conjugate and Hepatitis B VacciHepatitis B VaccineMerck KGaARecombivax

1 to 9 of 133 results

COMPANY SPOTLIGHT

Menarini

Back to top